Related Experiment Video
Updated: Jul 7, 2025

03:42
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
1.5K
Bidirectional causal relationship between hypercholesterolemia and ischemic heart disease: a Mendelian randomization
Ying Jiang1, Wenpeng Yu1, Jianliang Zhou2
1Department of Cardiovascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Frontiers in Cardiovascular Medicine
|December 25, 2023
Summary
This study used genetic data to show that high cholesterol (hypercholesterolemia) and ischemic heart disease (IHD) have a two-way causal link. Shared genes like APOE were identified, suggesting new treatment targets for both conditions.
Area of Science:
- Cardiovascular Genetics
- Metabolic Disorders
- Epidemiology
Background:
- Ischemic heart disease (IHD) is a major global health concern.
- Hypercholesterolemia, characterized by high cholesterol levels, is linked to IHD.
- The precise causal relationship between hypercholesterolemia and IHD requires further elucidation.
Purpose of the Study:
- To investigate the bidirectional causal relationship between hypercholesterolemia and IHD using genetic evidence.
- To identify shared genetic factors contributing to both conditions.
- To explore potential therapeutic targets based on genetic insights.
Main Methods:
- A two-sample Mendelian randomization (MR) analysis was performed.
- Genetic variants associated with hypercholesterolemia and IHD were utilized.
- Multiple statistical methods (MR-Egger, IVW, Weighted Median) and sensitivity analyses were employed.
- Genetic co-localization analysis was conducted to identify shared genes.
Main Results:
- A significant bidirectional causal relationship was confirmed between hypercholesterolemia and IHD.
- Increased odds of IHD were associated with hypercholesterolemia (OR=2.27).
- Increased odds of hypercholesterolemia were associated with IHD (OR=1.80).
- Four genes (CELSR2, PCSK9, LPA, APOE) were identified as co-localized and potentially implicated in both conditions.
Conclusions:
- Mendelian randomization provides genetic evidence for a causal link between hypercholesterolemia and IHD.
- The findings support a bidirectional relationship, with IHD potentially influencing hypercholesterolemia.
- Co-localization analysis suggests shared genetic causal variants, offering targets for novel therapeutic strategies.
Related Concept Videos
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Cholesterol: Significance and Regulation
551
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
551
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
519
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
519

